GreenLight's strategic partnerships are key to help take our innovation to market faster.
In collaboration with industrial partners and the US government, GreenLight is developing specific Cell-free Bioprocessing pathways for important compounds in the following areas:
Novel and efficient production of a central nervous system API
Sustainable production of food ingredients
Novel production of bio-insecticides respectful with the environment
Novel production of methane into chemicals (ARPA-e)
GreenLight is researching novel Cell-free Bioprocessing production approaches for three new families of molecules and reaching out to industry for partners for development and commercialization.
Anti-metabolites for HIV, HCV, and anti cancer applications
Rare sugars, Ribose, and Ribose derivatives
High Purity Fatty Acids
Companies interested learning more about partnership opportunities please contact us at firstname.lastname@example.org with the subject "Partnering".